INDITEX : The trend should continue
Entry price | Target | Stop-loss | Potential |
---|
€24.1 |
€26.66 |
€22.65 |
+10.62% |
---|
Shares in INDITEX have recently benefitted from a regain of interest by market participants. The technical chart pattern suggests a continuation of the upward movement.
Summary● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
● According to Refinitiv, the company's ESG score for its industry is good.
Strengths● Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● This company will be of major interest to investors in search of a high dividend stock.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● For the past twelve months, EPS forecast has been revised upwards.
● Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses● The company appears highly valued given the size of its balance sheet.
● The group usually releases earnings worse than estimated.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.